Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Journal of Virology
|
October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants
Shilei Ding, Derek Yang, Irfan Ullah, et al.
Cell Reports
|
February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports
|
June 22, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Cell Reports
|
October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Nature Medicine
|
September 10, 2021
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity
|
August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Cell Reports. Medicine
|
October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe
|
June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Journal of Virology
|
October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants
Shilei Ding, Derek Yang, Irfan Ullah, et al.
Cell Reports
|
February 26, 2022
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports
|
June 22, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Cell Reports
|
October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Nature Medicine
|
September 10, 2021
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity
|
August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Cell Reports. Medicine
|
October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe
|
June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Page
of 7